Today: 21 May 2026
Browse Category

ASX:BHP 10 January 2026 - 27 January 2026

Australia stock market today: ASX 200 slips again as banks drag; Rio, gold stocks soften the blow

Australia stock market today: ASX 200 slips again as banks drag; Rio, gold stocks soften the blow

Australia’s ASX 200 fell 0.37% to 8,782.9, its third straight drop, as financial and real estate stocks slid 1.6%. Rio Tinto rose 2.6% after Pilbara shipments beat forecasts, while BHP shares dipped 2% on cost overruns and price concessions. Gold miners rallied, with Evolution Mining up 9.18% after strong output. Wall Street’s sharp fall and new US tariff threats hit risk appetite.
21 January 2026
····
BHP share price rebounds after China iron ore talks, potash cost jump rattles investors

BHP share price rebounds after China iron ore talks, potash cost jump rattles investors

BHP shares closed up 1.47% at A$48.48, rebounding after Tuesday’s drop. The company warned of price concessions in ongoing iron ore supply talks with China and raised its Jansen potash project cost estimate to $8.4 billion. Copper prices rose 32% year-on-year, and iron ore edged up 4%. Investors await BHP’s half-year results on Feb. 17.
21 January 2026
···
ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

The S&P/ASX 200 fell 0.4% by mid-morning Wednesday, led by declines in tech and banks, while miners rose on record gold prices near $4,762 an ounce. U.S. President Trump threatened new tariffs on eight European countries after their troops arrived in Greenland, escalating trade tensions. Lynas Rare Earths jumped on a 43% revenue surge. Rio Tinto reported record quarterly iron ore shipments.
21 January 2026
····
BHP share price slides after Jansen potash cost jump and China iron ore discounts

BHP share price slides after Jansen potash cost jump and China iron ore discounts

BHP shares closed down 2% at A$47.78 after the company warned of weaker realised iron ore prices and raised its Jansen Stage 1 potash project cost estimate to $8.4 billion. The miner kept its full-year iron ore forecast but lifted its copper outlook. BHP confirmed price cuts on some iron ore shipments amid contract talks with China. Iron ore futures in Asia also fell, with Rio Tinto and Fortescue shares declining.
20 January 2026
··
ASX 200 hits 11-week high as banks rebound and tech rallies in Australia stock market

ASX 200 hits 11-week high as banks rebound and tech rallies in Australia stock market

The S&P/ASX 200 closed up 0.48% at 8,903.9, its highest since October, led by gains in banks and tech. Westpac rose 1.8% to A$39.19, Macquarie climbed 2.6% to A$211.86. Energy and lithium stocks fell as oil and China lithium futures dropped. Investors now await key jobs data due Jan. 22.
16 January 2026
············
BHP share price slips after Pilbara tie-up with Rio Tinto as China iron ore signals stay mixed

BHP share price slips after Pilbara tie-up with Rio Tinto as China iron ore signals stay mixed

BHP shares fell 1.1% to A$48.85 in Sydney, reversing gains from the previous session. Rio Tinto and BHP announced a partnership to develop Pilbara iron ore deposits, targeting up to 200 million tonnes. Iron ore prices stayed volatile as China’s December imports hit a record 119.65 million tons. BHP’s operational review is scheduled for Jan. 20, with half-year earnings due Feb. 17.
16 January 2026
····
Australia stock market today: ASX 200 ends at two-month high as oil and copper lift miners, banks slide

Australia stock market today: ASX 200 ends at two-month high as oil and copper lift miners, banks slide

ASX 200 rose 0.14% to 8,820.6, its highest close since November, as energy and mining stocks advanced on record oil and copper prices. Major banks fell, with Commonwealth Bank down 1.3%, amid ongoing concerns over rising interest rates. Neuren Pharmaceuticals surged 6% after strong DAYBUE sales projections. Gold and silver miners rallied as bullion hit record highs.
14 January 2026
······
Australia stock market today: ASX 200 ends higher as miners, banks climb; Endeavour and GQG slide

Australia stock market today: ASX 200 ends higher as miners, banks climb; Endeavour and GQG slide

Australian shares closed up 0.56% at 8,808.50, led by gains in miners and banks, while energy stocks fell. BHP rose 2.3%, Rio Tinto 2.2%, and Endeavour Group dropped 2.9% on margin pressure. GQG Partners slid 8.6% after reporting US$2.1 billion in December net outflows. Investors await U.S. inflation data due Wednesday.
13 January 2026
·······
1 2 3 4 5 6

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop